PillRx only · Injection, Solution · Subcutaneous
Tbo-Filgrastim
Brands: Granix · Filgrastim
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
3.2K
Rx · 2026 Q1
7.2K
Units dispensed
+8%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Cephalon, LLC | unknown | 10 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 10, 2025RECALLRecall (Class II): Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 syringe in 1 CARTON, …
Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit — Recalling firm: Teva Pharmaceuticals USA, Inc — Product was distributed nationwide.